GKB Ophthalmics Share Price

GKB Ophthalmics Share Price

59.63
+0.17 (0.29%)
21 Jul, 2026 • 12:00 AM
BSE: 533212 | FMCG | Small Cap

GKB Ophthalmics Annualised Returns

1 Year

-23.50%

3 Years

-12.94%

5 Years

-9.04%

10 Years

-1.83%

GKB Ophthalmics Share Price Today


As of 22 Jul 2026, GKB Ophthalmics share price is ₹59.6. The stock opened at ₹60.2 and had closed at ₹59.5 the previous day. During today’s trading session, GKB Ophthalmics share price moved between ₹57.00 and ₹60.24, with an average price for the day of ₹58.62. Over the last 52 weeks, the stock has recorded a low of ₹45.25 and a high of ₹91.70. In terms of performance, GKB Ophthalmics share price has increased by 18.1% over the past six months and has declined by 23.5% over the last year.

GKB Ophthalmics Stock Performance

1W Return1.95%
1M Return-3.20%
6M Return6.08%
1Y Return-21.59%
3Y Return-31.74%
Today's High₹60.24
Today's Low₹57
52-Week High₹91.7
52-Week Low₹45.25
Prev. Close₹59.46
Open₹60.24
Face Value₹10
Mkt Cap (Cr.)₹30
PE Ratio-8.42

GKB Ophthalmics Share Price Chart

GKB Ophthalmics Company background

Founded in: 1981
Incorporated in December, 1981, GKB Opthalmics Limited was granted a licence as a 100% EOU in 1982. The Company set up a plant at Tivim, Goa, with financial assistance from the Economic Development Corporation of Goa, Daman and Diu Limited and The Maharashtra State Financial Corporation. Presently, the Company is engaged in manufacture and sale of unfinished ophthalmic lenses and manufactures 14,000 pieces per day of plastic lenses.The company is engaged in the manufacture and export of highquality, singlevision mineral opthalmic lenses. Commercial production commenced in May 83. It has an installed capacity of 30 lac lenses pa. The company completed the expansion programme by expanding the capacity of single vision lenses to 33 lac pcs pa. It also installed facilities for coating 1.72 lac pcs of lenses pa. The above project was completed at a new loacation Pilerne Industrial Estate, BardezGoa. The company has shifted the single vision plant to the new premises in phases. In 199697, it increased the installed capacity of ophthamal lenses by 9,00,000 nos to 30,00,000 nos.The establishment of Companys fully owned subsidiary in Germany in 1998 was a turning point in creating a strong market base in Europe. The company floated a wholly owned subsidiary (WOS) at Bermen, Germany which acted as a stock point and had oroper liasion with the buyers in and around Europe. During the year 200708, the Company started the production of CR 39 lenses in its Unit 2. On October 05, 2018, GSV Ophthalmics Private Limited was incorporated as Wholly Owned Subsidiary of the Company. GSV Ophthalmics Private Limited is another Subsidiary of the Company, which was incorporated to produce HiIndex Ophthalmic Lenses, however, the Project had become financially unviable and therefore the Company is in the discussion of coming up with an alternate expansion plan.

GKB Ophthalmics Financial Highlights


For the full year FY2026–2027, revenue reached ₹151.31 crore and profit touched at ₹3.09 crore.
Read More
GKB Ophthalmics SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 2,40,256 in 5 years with a gain of -59,743 (-19.91%)

GKB Ophthalmics Fundamental

Market Cap (in crs)

30.06

Face Value

10

Turnover (in lacs)

1.00

Key Metrics

Qtr Change %
34.97% Fall from 52W High
-17.5
Dividend yield 1yr %
0

GKB Ophthalmics Key Financials

View more
Loading chart...
GKB Ophthalmics Quarterly Revenue
GKB Ophthalmics Yearly Revenue
GKB Ophthalmics Quarterly Net Profit/Loss
GKB Ophthalmics Yearly Net Profit/Loss

GKB Ophthalmics Result Highlights

  • GKB Ophthalmics reported a 46.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 2.4%.
  • Its expenses for the quarter were down by 50.9% QoQ and 20.7% YoY.
  • The net profit increased 60.0% QoQ and decreased 127.1% YoY.
  • The earnings per share (EPS) of GKB Ophthalmics stood at 0.38 during Q4 FY 2025-26.

Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

GKB Ophthalmics Technical Analysis

Moving Averages Analysis
59.63
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
10
5 EMA
59.00
10 EMA
59.40
12 EMA
59.60
20 EMA
60.40
26 EMA
60.90
50 EMA
61.90
100 EMA
62.10
200 EMA
63.80
Delivery & Volume
Loading chart...

Day

55.30%

Week

82.50%

Month

88.20%

Delivery & Volume

58.96
Pivot
Resistance
First Resistance
60.91
Second Resistance
62.20
Third Resistance
64.15
Support
First Support
57.67
Second support
55.72
Third Support
54.43
Relative Strength Index
46.25
Money Flow Index
10.36
MACD
-1.33
MACD Signal
-1.23
Average True Range
2.73
Average Directional Index
27.25
Rate of Change (21)
-6.30
Rate of Change (125)
17.68
Compare

GKB Ophthalmics Shareholding Pattern

Promoter
51.2%
Foreign Institutions
1.8%
Public
47.1%

GKB Ophthalmics Latest News

14 JUL 2026
07 JUL 2026
30 JUN 2026

GKB Ophthalmics share price in the past 1-year return was -21.59. The GKB Ophthalmics share hit a 1-year low of Rs. 45.25 and a 1-year high of Rs. 91.7.

The market cap of GKB Ophthalmics is Rs. 30.06 Cr. as of 21/7/2026.

The PE ratios of GKB Ophthalmics is -8.42 as of 21/7/2026.

The PB ratios of GKB Ophthalmics is 2.09 as of 21/7/2026

You can easily buy GKB Ophthalmics shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of GKB Ophthalmics share price is ₹91.7 and ₹45.25 as of 21/7/2026.

Please be aware that GKB Ophthalmics stock prices are subject to continuous fluctuations due to various factors.